Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Weimar

Showing results (331-340 of 436) with videos related to

Pageof 44
Sort By:
Lancet (London, England)|December 17, 1977
Fibroblast interferon in HBsAg-positive chronic active hepatitisW Weimar, R A Heijtink, S W Schalm, et al.
Surgical Endoscopy|February 13, 2003
Live donor nephrectomy and return to work: does the operative technique matter?M Y Lind, Y S Liem, W A Bemelman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Donor-specific CTL frequencies in peripheral blood in relation to graft vascular disease after clinical heart transplantationN M van Besouw, C R Daane, P de Kuiper, et al.
Transplant Immunology|December 16, 1998
Kinetics of circulating cytotoxic T lymphocyte precursors that have a high avidity for donor antigens: correlation with the rejection status of the human cardiac allograftN E van Emmerik, L M Vaessen, C J Knoop, et al.
Transplantation Proceedings|March 27, 2001
Proteinuria and death risk in the renal transplant populationJ I Roodnat, P G Mulder, J Rischen-Vos, et al.
Clinical Transplantation|February 29, 2000
A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZAB J van der Mast, N M van Besouw, P de Kuiper, et al.
Kidney International|March 7, 2001
T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxisI C van Riemsdijk, C C Baan, E H Loonen, et al.
Immunopharmacology|September 1, 1995
Pharmacodynamics of prophylactic antirejection therapy with an anti interleukin-2 receptor monoclonal antibody (BT563) after heart and kidney transplantationC J Hesse, T van Gelder, L M Vaessen, et al.
Clinical and Experimental Immunology|August 1, 1994
Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplantsC C Baan, N E van Emmerik, A H Balk, et al.
Transplantation Proceedings|February 1, 1991
A comparison between heterotopic and orthotopic liver transplantation in patients with end-stage chronic liver diseaseH J Metselaar, E J Hesselink, S de Rave, et al.
Pageof 44

Showing results (331-340 of 436) with videos related to

Sort By:
Pageof 44
Lancet (London, England)|December 17, 1977
Fibroblast interferon in HBsAg-positive chronic active hepatitisW Weimar, R A Heijtink, S W Schalm, et al.
Surgical Endoscopy|February 13, 2003
Live donor nephrectomy and return to work: does the operative technique matter?M Y Lind, Y S Liem, W A Bemelman, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 17, 1998
Donor-specific CTL frequencies in peripheral blood in relation to graft vascular disease after clinical heart transplantationN M van Besouw, C R Daane, P de Kuiper, et al.
Transplant Immunology|December 16, 1998
Kinetics of circulating cytotoxic T lymphocyte precursors that have a high avidity for donor antigens: correlation with the rejection status of the human cardiac allograftN E van Emmerik, L M Vaessen, C J Knoop, et al.
Transplantation Proceedings|March 27, 2001
Proteinuria and death risk in the renal transplant populationJ I Roodnat, P G Mulder, J Rischen-Vos, et al.
Clinical Transplantation|February 29, 2000
A longitudinal study of TGF-beta1 protein levels in renal allograft recipients converted from CsA to MMF or AZAB J van der Mast, N M van Besouw, P de Kuiper, et al.
Kidney International|March 7, 2001
T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxisI C van Riemsdijk, C C Baan, E H Loonen, et al.
Immunopharmacology|September 1, 1995
Pharmacodynamics of prophylactic antirejection therapy with an anti interleukin-2 receptor monoclonal antibody (BT563) after heart and kidney transplantationC J Hesse, T van Gelder, L M Vaessen, et al.
Clinical and Experimental Immunology|August 1, 1994
Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplantsC C Baan, N E van Emmerik, A H Balk, et al.
Transplantation Proceedings|February 1, 1991
A comparison between heterotopic and orthotopic liver transplantation in patients with end-stage chronic liver diseaseH J Metselaar, E J Hesselink, S de Rave, et al.
Pageof 44